Follow
Alexandra Litvinchuk
Alexandra Litvinchuk
Washington University School of Medicine
Verified email at wustl.edu
Title
Cited by
Cited by
Year
Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer's disease
H Lian, A Litvinchuk, ACA Chiang, N Aithmitti, JL Jankowsky, H Zheng
Journal of Neuroscience 36 (2), 577-589, 2016
5582016
Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer’s disease
A Litvinchuk, YW Wan, DB Swartzlander, F Chen, A Cole, NE Propson, ...
Neuron 100 (6), 1337-1353. e5, 2018
4032018
Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging
NE Propson, ER Roy, A Litvinchuk, J Köhl, H Zheng
The Journal of Clinical Investigation 131 (1), 2021
1732021
ApoE4 reduction with ASOs decreases neurodegeneration in a tauopathy model
A Litvinchuk, TPV Huynh, Y Shi, RJ Jackson, MB Finn, M Manis, ...
Annals of Neurology, 2021
652021
Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist
A Litvinchuk, JH Suh, JL Guo, K Lin, SS Davis, N Bien-Ly, E Tycksen, ...
Neuron, 2023
502023
A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1
CA Lasagna-Reeves, MWC Rousseaux, MJ Guerrero-Muñoz, J Park, ...
Elife 4, e07558, 2015
372015
Mitochondrially-encoded protein Var1 promotes loss of respiratory function in Saccharomyces cerevisiae under stressful conditions
AV Litvinchuk, SS Sokolov, AG Rogov, OV Markova, DA Knorre, ...
European journal of cell biology 92 (4-5), 169-174, 2013
72013
Advancements in APOE and dementia research: Highlights from the 2023 AAIC Advancements: APOE conference
CM Kloske, ME Belloy, EE Blue, GR Bowman, MC Carrillo, X Chen, ...
Alzheimer's & Dementia, 0
6
Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes
JL Guo, D Braun, GA Fitzgerald, YT Hsieh, L Rougé, A Litvinchuk, ...
Cell, 2024
52024
[O1–14–03]: THE ROLE OF COMPLEMENT C3 AND C3AR RECEPTOR IN TAU PATHOLOGY IN ALZHEIMER's DISEASE
A Litvinchuk, YW Wan, A Cole, F Chen, Z Liu, H Zheng
Alzheimer's & Dementia 13 (7S_Part_4), P229-P229, 2017
32017
The relationship between ApoE4 and lipid dysregulation in glia of the PS19 mouse model of tauopathy
A Litvinchuk
Alzheimer's & Dementia 19, e071023, 2023
2023
Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging
NE Propson, ER Roy, A Litvinchuk, J Köhl, H Zheng
Journal of Clinical Investigation 131 (1), 1-17, 2021
2021
INCREASED C3 IN THE AGING BRAIN PROMOTES INFLAMMATORY TRANSITION IN ENDOTHELIAL CELLS
NE Propson, A Litvinchuk, ER Roy, B Contreras, W Cao, H Zheng
Innovation in Aging 3 (Suppl 1), S840, 2019
2019
Complement C3 and C3aR Signaling Regulates Neuropathology and Neuro-immune Network in Alzheimer's Disease
A Litvinchuk
Baylor College of Medicine Integrative Molecular and Biomedical Sciences …, 2019
2019
Complement C3 and C3aR receptor promote tau pathology and Alzheimers disease
A Litvinchuk, YW Wan, Z Liu, H Zheng
JOURNAL OF NEUROCHEMISTRY 142, 158-158, 2017
2017
Author response: A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1
CA Lasagna-Reeves, MWC Rousseaux, MJ Guerrero-Muñoz, J Park, ...
(No Title), 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–16